HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduction in muscarinic M1-mediated hypercholinergic state and beneficial cognitive effects of muscarinic agonists in schizophrenia.

AuthorsNunzio Pomara
JournalThe American journal of psychiatry (Am J Psychiatry) Vol. 166 Issue 1 Pg. 111; author reply 111-3 (Jan 2009) ISSN: 1535-7228 [Electronic] United States
PMID19122018 (Publication Type: Comment, Letter)
Chemical References
  • Muscarinic Agonists
  • Pyridines
  • Receptor, Muscarinic M1
  • Thiadiazoles
  • xanomeline
  • Acetylcholine
  • Dopamine
Topics
  • Acetylcholine (metabolism)
  • Cognition Disorders (diagnosis, drug therapy)
  • Dopamine (metabolism)
  • Hippocampus (drug effects)
  • Humans
  • Muscarinic Agonists (adverse effects, therapeutic use)
  • Neocortex (drug effects)
  • Pyridines (adverse effects, therapeutic use)
  • Receptor, Muscarinic M1 (drug effects)
  • Schizophrenia (diagnosis, drug therapy)
  • Thiadiazoles (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: